58 related articles for article (PubMed ID: 31828091)
1. Clinicopathological and Prognostic Significance of WW Domain Binding Protein 5 Expression in Papillary Thyroid Carcinoma.
Qian Y; Pan Z; Guo Z; Ge X; Zheng G; Cao J; Huang P; Zhu X; Zhu X; Wen Q; Ge M
Biomed Res Int; 2019; 2019():1791065. PubMed ID: 31828091
[TBL] [Abstract][Full Text] [Related]
2. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer.
Scholfield DW; Fitzgerald CW; Alzumaili B; Eagan A; Xu B; Martinez G; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein RA; Ganly I
Ann Surg Oncol; 2023 Aug; 30(8):4761-4770. PubMed ID: 37154968
[TBL] [Abstract][Full Text] [Related]
3. Tumor keratin 15 expression links with less extent of invasion and better prognosis in papillary thyroid cancer patients receiving tumor resection.
Yang X; Liu Z; Wang X; Han Z; Zhang C; Guo L
Ir J Med Sci; 2024 Feb; 193(1):9-15. PubMed ID: 37243844
[TBL] [Abstract][Full Text] [Related]
4. Homogentisic acid metabolism inhibits papillary thyroid carcinoma proliferation through ROS and p21-induced cell cycle arrest.
Xie R; Lin J; Li W; Chen H; Zhang J; Zhong M; Xue J; Mo C; Chen L; Zhu Y; Chen X; Xu S
Life Sci; 2024 Jun; 347():122682. PubMed ID: 38702025
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 Expression and Ultrasound Characteristics in Papillary Thyroid Carcinoma and Its Effect on Recurrence.
Li R; Li M; Sun B; Qi M; Peng C; Li H; Zheng S; Liu Q; Jiang C
In Vivo; 2023; 37(6):2820-2828. PubMed ID: 37905619
[TBL] [Abstract][Full Text] [Related]
6. WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway.
Tang R; Lei Y; Hu B; Yang J; Fang S; Wang Q; Li M; Guo L
Br J Cancer; 2016 Jul; 115(2):243-51. PubMed ID: 27336605
[TBL] [Abstract][Full Text] [Related]
7. A novel risk stratification model based on tumor size and multifocality to predict recurrence in pediatric PTC: comparison with adult PTC.
Du R; Zhang Y; Kou J; Li J; Sui C; Zhang D; Fu Y; Zhou L; Fu Q; Li F; Dionigi G; Liang N; Sun H
Front Endocrinol (Lausanne); 2023; 14():1298036. PubMed ID: 38274235
[TBL] [Abstract][Full Text] [Related]
8. The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis.
Jin T; Wang W; Ge L; Li X; Ge M
Endocrine; 2023 Dec; 82(3):590-601. PubMed ID: 37480496
[TBL] [Abstract][Full Text] [Related]
9. Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review.
Buczyńska A; Kościuszko M; Krętowski AJ; Popławska-Kita A
Front Endocrinol (Lausanne); 2023; 14():1261860. PubMed ID: 38089632
[TBL] [Abstract][Full Text] [Related]
10. An individualized protein-based prognostic model to stratify pediatric patients with papillary thyroid carcinoma.
Wang Z; Wang H; Zhou Y; Li L; Lyu M; Wu C; He T; Tan L; Zhu Y; Guo T; Wu H; Zhang H; Sun Y
Nat Commun; 2024 Apr; 15(1):3560. PubMed ID: 38671151
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.
Lan X; Bao H; Ge X; Cao J; Fan X; Zhang Q; Liu K; Zhang X; Tan Z; Zheng C; Wang A; Chen C; Zhu X; Wang J; Xu J; Zhu X; Wu X; Wang X; Shao Y; Ge M
Cancer Sci; 2020 Jun; 111(6):2163-2173. PubMed ID: 32187423
[TBL] [Abstract][Full Text] [Related]
12. Transoral versus gasless transaxillary endoscopic thyroidectomy: a comparative study.
Zheng G; Xu J; Wu G; Ma C; Sun H; Ge M; Zheng H; Zheng C
Updates Surg; 2022 Feb; 74(1):295-302. PubMed ID: 33914272
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Proteomics Profiles Between Xenografts Derived from Cell Lines and Primary Tumors of Thyroid Carcinoma.
Fang L; Liu YJ; Zhang YW; Pan ZF; Zhong LK; Jiang LH; Wang JF; Zheng XW; Chen LY; Huang P; Ge MH; Tan Z
J Cancer; 2021; 12(7):1978-1989. PubMed ID: 33753996
[TBL] [Abstract][Full Text] [Related]
14. Role of oncogene PIM-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress.
Wen QL; Yi HQ; Yang K; Yin CT; Yin WJ; Xiang FY; Bao M; Shuai J; Song YW; Ge MH; Zhu X
Mol Cell Endocrinol; 2021 Mar; 523():111144. PubMed ID: 33383107
[TBL] [Abstract][Full Text] [Related]
15. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Pan Z; Fang Q; Li L; Zhang Y; Xu T; Liu Y; Zheng X; Tan Z; Huang P; Ge M
Cancer Lett; 2021 Mar; 501():31-42. PubMed ID: 33359451
[TBL] [Abstract][Full Text] [Related]
16. Predictive Risk-scoring Model For Central Lymph Node Metastasis and Predictors of Recurrence in Papillary Thyroid Carcinoma.
Jiang LH; Yin KX; Wen QL; Chen C; Ge MH; Tan Z
Sci Rep; 2020 Jan; 10(1):710. PubMed ID: 31959758
[TBL] [Abstract][Full Text] [Related]
17. Concomitant papillary thyroid carcinoma and mucosa-associated lymphoid tissue thyroid lymphoma in the setting of Hashimoto thyroiditis.
Lan XB; Cao J; Zhu XH; Han Z; Huang YQ; Ge MH; Yang HY
Int J Clin Exp Pathol; 2018; 11(6):3076-3083. PubMed ID: 31938434
[TBL] [Abstract][Full Text] [Related]
18. The impact of
Yin W; Xia X; Wu M; Yang H; Zhu X; Sun W; Ge M
Int J Clin Exp Pathol; 2019; 12(6):2215-2223. PubMed ID: 31934044
[TBL] [Abstract][Full Text] [Related]
19. TCR-Seq Identifies Distinct Repertoires of Distant-Metastatic and Nondistant-Metastatic Thyroid Tumors.
Lan X; Cao J; Ye K; Zhang C; Zhang Q; Ge X; Wang C; Zhang C; Tai Z; Wei W; Huang Y; Yi X; Tan Z; Zheng C; Chen C; Zhu X; Wang J; Xu J; Zhu X; Ge M
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32674137
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of mRNA 3'-end isoforms in cervical and ovarian cancers.
Dioken DN; Ozgul I; Koksal Bicakci G; Gol K; Can T; Erson-Bensan AE
Heliyon; 2023 Sep; 9(9):e20035. PubMed ID: 37810050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
